Evidence map›Paper›PMID 35313308›Full record

ArticleNeonatology2022

Evaluation of the Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants with Necrotizing Enterocolitis.

Angela N Lewis, Diomel de la Cruz, James L Wynn, Lauren C Frazer, William Yakah, Camilia R Martin, Heeju Yang, Elena Itriago, Jana Unger, Amy B Hair and 4 more

2 registry-linked trialsOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Neonatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07207915 completednot on this mapstarted 2023, after this paper: background citation

Analysis of Integrated Clinical, Laboratory and Prognostic Data of Neonates With Necrotizing Enterocolitis

TypeobservationalSponsorSixth Affiliated Hospital, Sun Yat-sen UniversityRan2023 to 2025Enrolled400ConditionsNecrotizing EnterocolitisArmsObservational retrospective cohort study
NCT07249697 completednot on this map

Risk Factors for Poor Prognosis in Neonatal Necrotizing Enterocolitis

TypeobservationalSponsorGuangzhou Women and Children's Medical CenterRan2017 to 2025Enrolled118ConditionsNecrotizing EnterocolitisArmsObservational retrospective cohort study
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Current operative approaches for necrotizing enterocolitis.World journal of pediatric surgery · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. The utility of neonatal sequential organ failure assessment in mortality risk in all neonates with suspected late-onset infection.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Angela N LewisDivision of Newborn Medicine, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA.
Diomel de la CruzDivision of Neonatology, Department of Pediatrics, UF Health Shands Children's Hospital, University of Florida College of Medicine, Gainesville, Florida, USA.
James L WynnDivision of Neonatology, Department of Pediatrics, UF Health Shands Children's Hospital, University of Florida College of Medicine, Gainesville, Florida, USA.
Lauren C FrazerDivision of Newborn Medicine, Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA.
William YakahDivision of Newborn Medicine, Department of Pediatrics, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Camilia R MartinDivision of Newborn Medicine, Department of Pediatrics, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, USA.
Heeju YangSection of Neonatology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
Elena ItriagoSection of Neonatology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
Jana UngerSection of Neonatology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
Amy B HairSection of Neonatology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
Jessica MieleUVA Children's Hospital, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Brynne A SullivanDivision of Neonatology, Department of Pediatrics, UVA Children's Hospital, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Ameena HusainDivision of Newborn Medicine, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA.
Misty GoodDivision of Newborn Medicine, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA.
Baylor College of Medicine · USSt. Louis Children's Hospital · USBoston Children's Hospital · USUF Health Shands Hospital · USUniversity of Virginia Children's Hospital · USBeth Israel Deaconess Medical Center · US

Funding

Neonatal Research Training ProgramT32HD098061 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Stella Kourembanas, Martha C. Sola-Visner · 2019 to 2026
$4.0M
Salivary Diagnostics for Sepsis Screening in the NeonateR01HD097081 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI MARON, JILL LAMANNA, WALT, DAVID R. · 2019 to 2023
$3.6M
Microfluidic Assessment of Clinical Outcomes in Preterm NewbornsR01HD089939 · NICHD · UNIVERSITY OF FLORIDA · PI IRIMIA, DANIEL, MOLDAWER, LYLE L · 2017 to 2021
$3.3M
Non-invasive analysis of methylated cell free DNA in necrotizing enterocolitisR01DK124614 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L, PETERS, DAVID GERARD · 2021 to 2024
$2.5M
Neonatal gut-on-a-chip platform for high content drug testing and precision medicineR01HD105301 · NICHD · WASHINGTON UNIVERSITY · PI GOOD, MISTY L, MAGNESS, SCOTT T · 2021 to 2024
$2.4M
Phenotypic Driven Growth Trajectories in Very Preterm Infants to Define Nutritionally Mediated Health Outcomes and Modifiable TargetsR01HD106359 · NICHD · YALE UNIVERSITY · PI MARTIN, CAMILIA R, TAYLOR, SARAH N · 2021 to 2025
$2.1M
Modifiable Determinants of Mortality in Neonatal SepsisR01GM128452 · NIGMS · UNIVERSITY OF FLORIDA · PI WYNN, JAMES LAWRENCE · 2018 to 2022
$1.9M
Modulation of the Intestinal Immune Response in Necrotizing EnterocolitisR01DK118568 · NIDDK · WASHINGTON UNIVERSITY · PI GOOD, MISTY L · 2018 to 2022
$1.8M
A New Tool to Rapidly Diagnose Sepsis using Flow Imaging Microscopy and Machine LearningR43EB029863 · NIBIB · URSA ANALYTICS, INC. · PI CALDERON, CHRISTOPHER PETER, RANDOLPH, THEODORE W · 2020 to 2020
$225k
NIBIB NIH HHS R43 EB029863NICHD NIH HHS R01 HD089939NICHD NIH HHS R01 HD097081NICHD NIH HHS R01 HD105301NICHD NIH HHS R01 HD106359NICHD NIH HHS T32 HD098061NIDDK NIH HHS R01 DK118568NIDDK NIH HHS R01 DK124614NIGMS NIH HHS R01 GM128452
6 · The paper itself

Abstract

introductionThe neonatal sequential organ failure assessment (nSOFA) score is a tool for calculating mortality risk of infants in the neonatal intensive care unit. The utility of the nSOFA in determining the risk of mortality or the association with surgical intervention among infants with necrotizing enterocolitis (NEC) has not been investigated.

methodsWe performed a retrospective, cohort study of preterm (<37 weeks) infants with NEC Bell's stage ≥ IIA at six hospitals from 2008 to 2020. An nSOFA score (range 0-15) was assigned to each patient at nine time points from 48 h before or after clinical illness was suspected.

resultsOf the 259 infants, nSOFA scores for infants who died (n = 39) or had the composite outcome of surgery or death (n = 114) were significantly higher (p < 0.05) early in the NEC course compared to nSOFA scores for infants who survived medical NEC. Twelve hours after evaluation, the area under the receiver operating characteristic curve was 0.87 (95% confidence interval [CI], 0.80-0.93) to discriminate for mortality and 0.84 (95% CI, 0.79-0.90) for surgery or death (p < 0.001). A maximum nSOFA score of ≥4 at -6, 0, 6, or 12 h following evaluation was associated with a 20-fold increase in mortality and 19-fold increase in surgery or death compared with a score of <4 (p < 0.001).

conclusionIn this multicenter cohort, the nSOFA score was able to discriminate well for death as well as surgery or death among infants with NEC. The nSOFA is a clinical research tool that may be used in infants with NEC to improve classification by objective quantification of organ dysfunction.

Indexed as

Enterocolitis, NecrotizingInfant, Newborn, DiseasesCohort StudiesHumansInfantInfant, NewbornInfant, PrematureOrgan Dysfunction ScoresRetrospective StudiesIllness severityNecrotizing enterocolitisNeonateOrgan dysfunction

Identifiers

PMID35313308
PMCPMC9117503
OpenAlexW4221014051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.